Financhill
Sell
16

XPOF Quote, Financials, Valuation and Earnings

Last price:
$5.51
Seasonality move :
-13.27%
Day range:
$4.44 - $5.87
52-week range:
$3.83 - $13.70
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.61x
P/B ratio:
--
Volume:
1.8M
Avg. volume:
697.2K
1-year change:
-57.4%
Market cap:
$194.5M
Revenue:
$314.9M
EPS (TTM):
-$1.46

Analysts' Opinion

  • Consensus Rating
    Xponential Fitness, Inc. has received a consensus rating of Hold. The company's average rating is a Hold based on 4 Buy ratings, 6 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $8.55, Xponential Fitness, Inc. has an estimated upside of 54.61% from its current price of $5.53.
  • Price Target Downside
    According to analysts, the lowest downside price target is $6.00 representing -8.5% downside risk from its current price of $5.53.

Fair Value

  • According to the consensus of 10 analysts, Xponential Fitness, Inc. has 54.61% upside to fair value with a price target of $8.55 per share.

XPOF vs. S&P 500

  • Over the past 5 trading days, Xponential Fitness, Inc. has underperformed the S&P 500 by -32.72% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • Xponential Fitness, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Xponential Fitness, Inc. revenues have been falling on a year-over-year basis for 5 quarters in a row. In the most recent quarter Xponential Fitness, Inc. reported revenues of $83M.

Earnings Growth

  • Xponential Fitness, Inc. has grown year-over-year earnings for 4 quarters straight. In the most recent quarter Xponential Fitness, Inc. reported earnings per share of -$1.17.
Enterprise value:
570.4M
EV / Invested capital:
3.73x
Price / LTM sales:
0.61x
EV / EBIT:
7.17x
EV / Revenue:
1.81x
PEG ratio (5yr expected):
-0.07x
EV / Free cash flow:
25.12x
Price / Operating cash flow:
8.47x
Enterprise value / EBITDA:
6.23x
Gross Profit (TTM):
$238.1M
Return On Assets:
-14%
Net Income Margin (TTM):
-17.05%
Return On Equity:
--
Return On Invested Capital:
-29.87%
Operating Margin:
17.58%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-12-31 2024-12-31 2025-12-31 2024-12-31 2025-12-31
Income Statement
Revenue $317.8M $320.3M $314.9M $83.2M $83M
Gross Profit $226.6M $221.5M $238.1M $58.9M $63.6M
Operating Income $43.5M $72.8M $79.5M $19.5M $14.6M
EBITDA $70.1M $90.5M $91.6M $24M $17M
Diluted EPS -$1.07 -$2.24 -$1.46 -$1.36 -$1.17
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Balance Sheet
Current Assets $47.5M $81.6M $90.1M $79.5M $91M
Total Assets $415.5M $482.7M $529.5M $403.4M $345.6M
Current Liabilities $65.9M $72.8M $102.2M $107.9M $116M
Total Liabilities $349.1M $382.7M $624.4M $597.4M $717.6M
Total Equity $66.4M $100M -$94.9M -$194M -$372M
Total Debt $130.9M $166.7M $396M $371M $520M
Trailing 12 Months Fiscal Quarters
Period Ending 2023-12-31 2024-12-31 2025-12-31 2024-12-31 2025-12-31
Cash Flow Statement
Cash Flow Operations $32.7M $11.7M $28.3M $762K $10.7M
Cash From Investing -$11.7M -$14.1M $1.5M -$215K $3.8M
Cash From Financing -$21.3M -$1.9M -$16.7M -$5.6M -$10.1M
Free Cash Flow $23.3M $6.2M $22.7M $484K $8.6M
XPOF
Sector
Market Cap
$194.5M
$320.3M
Price % of 52-Week High
40.37%
72.33%
Dividend Yield
0%
0%
Shareholder Yield
35.1%
2.22%
1-Year Price Total Return
-57.4%
-4.32%
Beta (5-Year)
--
0.521
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
9.3%
Growth streak:
0 years

Technicals

8-day SMA
Sell
Level $6.50
200-day SMA
Sell
Level $8.13
Bollinger Bands (100)
Sell
Level 6.39 - 8.37
Chaikin Money Flow
Sell
Level -12.9M
20-day SMA
Sell
Level $7.62
Relative Strength Index (RSI14)
Sell
Level 33.49
ADX Line
Sell
Level 26.15
Williams %R
Neutral
Level -63.9831
50-day SMA
Sell
Level $7.94
MACD (12, 26)
Sell
Level -0.70
25-day Aroon Oscillator
Sell
Level -76
On Balance Volume
Sell
Level -11.6M

Financial Scores

Sell
Altman Z-Score (Annual)
Level (-1.1738)
Sell
CA Score (Annual)
Level (-3.7341)
Buy
Beneish M-Score (Annual)
Level (-4.2902)
Sell
Momentum Score
Level (2)
Sell
Ohlson Score
Level (11.6692)
Buy
Piotroski F Score (Annual)
Level (7)
Buy
Quality Ratio Score
Level (9)
Sell
Fundamental Score
Level (3)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Xponential Fitness, Inc. is a curator of boutique fitness brands across multiple verticals. It operates as a boutique fitness franchisor in the United States with studios operating across distinct brands. The company's portfolio of brands spans a variety of fitness and wellness verticals, including cycling, stretch, rowing, yoga, boxing, dance and running. Its brands include Club Pilates, Pure Barre, CycleBar, StretchLab, Row House, YogaSix Rumble, AKT, and STRIDE. The company was founded on August 11, 2017 and is headquartered in Irvine, CA.

Stock Forecast FAQ

In the current month, XPOF has received 4 Buy ratings 6 Hold ratings, and 0 Sell ratings. The XPOF average analyst price target in the past 3 months is $8.55.

  • Where Will Xponential Fitness, Inc. Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Xponential Fitness, Inc. share price will rise to $8.55 per share over the next 12 months.

  • What Do Analysts Say About Xponential Fitness, Inc.?

    Analysts are divided on their view about Xponential Fitness, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Xponential Fitness, Inc. is a Sell and believe this share price will drop from its current level to $6.00.

  • What Is Xponential Fitness, Inc.'s Price Target?

    The price target for Xponential Fitness, Inc. over the next 1-year time period is forecast to be $8.55 according to 10 Wall Street analysts, 4 of them rate the stock a Buy, 0 rate the stock a Sell, and 6 analysts rate the stock a Hold.

  • Is XPOF A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Xponential Fitness, Inc. is a Hold. 6 of 10 analysts rate the stock a Hold at this time.

  • How Can I Buy Shares Of XPOF?

    You can purchase shares of Xponential Fitness, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Xponential Fitness, Inc. shares.

  • What Is The Xponential Fitness, Inc. Share Price Today?

    Xponential Fitness, Inc. was last trading at $5.51 per share. This represents the most recent stock quote for Xponential Fitness, Inc.. Yesterday, Xponential Fitness, Inc. closed at $5.53 per share.

  • How To Buy Xponential Fitness, Inc. Stock Online?

    In order to purchase Xponential Fitness, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Celestica The Best AI Stock to Buy Now?
Is Celestica The Best AI Stock to Buy Now?

Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…

Will AI Disrupt SaaS Software Stocks?
Will AI Disrupt SaaS Software Stocks?

Since January 28th, software stocks in the United States have…

Why Is Meta Stock Going Higher?
Why Is Meta Stock Going Higher?

Over the last five days, shares of Instagram and Facebook…

Stock Ideas

Sell
49
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 37x

Sell
46
Is AAPL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 35x

Sell
42
Is GOOG Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 28x

Alerts

Buy
93
NBTX alert for Mar 5

Nanobiotix SA [NBTX] is down 2% over the past day.

Sell
45
MRNA alert for Mar 5

Moderna, Inc. [MRNA] is down 0.74% over the past day.

Buy
77
SSRM alert for Mar 5

SSR Mining, Inc. [SSRM] is down 3.25% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock